Evidence map›Paper›PMID 18502416›Full record

ReviewExperimental and molecular pathology2008

High resolution melting applications for clinical laboratory medicine.

Maria Erali, Karl V Voelkerding, Carl T Wittwer

Open access · greenAbstract readReview
In one paragraph

Review in Experimental and molecular pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 2 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 2 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. First report ofOpen veterinary journal · 2026
    Article
  6. African journal of laboratory medicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maria EraliARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City, UT 84108, USA. maria.erali@aruplab.com
Karl V Voelkerding
Carl T Wittwer
University of Utah · USARUP Laboratories (United States) · US

Funding

Homogeneous Mutation ScanningR42GM072419 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 2004 to 2006
$850k
A System for Rapid PCR, Mutation Scanning and GenotypingR42GM073396 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 2005 to 2006
$850k
NIGMS NIH HHS R42 GM072419NIGMS NIH HHS R42 GM073396
6 · The paper itself

Abstract

Separation of the two strands of DNA with heat (melting) is a fundamental property of DNA that is conveniently monitored with fluorescence. Conventional melting is performed after PCR on any real-time instrument to monitor product purity (dsDNA dyes) and sequence (hybridization probes). Recent advances include high resolution instruments and saturating DNA dyes that distinguish many different species. For example, mutation scanning (identifying heterozygotes) by melting is closed-tube and has similar or superior sensitivity and specificity compared to methods that require physical separation. With high resolution melting, SNPs can be genotyped without probes and more complex regions can be typed with unlabeled hybridization probes. Highly polymorphic HLA loci can be melted to establish sequence identity for transplantation matching. Simultaneous genotyping with one or more unlabeled probes and mutation scanning of the entire amplicon can be performed at the same time in the same tube, vastly decreasing or eliminating the need for re-sequencing in genetic analysis. High resolution PCR product melting is homogeneous, closed-tube, rapid (1-5 min), non-destructive and does not require covalently-labeled fluorescent probes. In the clinical laboratory, it is an ideal format for in-house testing, with minimal cost and time requirements for new assay development.

Indexed as

Molecular Diagnostic TechniquesDNADNA Mutational AnalysisDNA ProbesGenotypeHumansNucleic Acid DenaturationDNADNA Probes

Identifiers

PMID18502416
PMCPMC2606052
OpenAlexW2066954795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.